News

A recent study found that children with a family history of type 2 diabetes show slower progression of type 1 diabetes.

As people with T1D live longer, age-related conditions such as dementia are becoming increasingly important.

Why normal glucose regulation should be the therapeutic goal rather than weight loss

How large is the benefit of combining the GLP-1 and amylin mechanisms of action, and what are the implications for clinical practice?

Phase II trial shows that higher doses of up to 16 mg of the GLP-1 receptor agonist (RA) semaglutide improve glycaemia and induce weight loss at the cost of reduced tolerability.

A post-hoc MRI substudy of the SURPASS-3 trial suggests that tirzepatide may improve muscle fat content in people with type 2 diabetes undergoing substantial weight loss.

Viruses are increasingly being explored as contributors to chronic diseases, including in diabetes research.

A recent study provides evidence that losing more than 10 % of body weight early after diabetes diagnosis can significantly improve longterm glycaemic control and increase remission rates. Based on up to 25 ...

Recent reports of unreliable continuous glucose monitoring (CGM) systems highlight the urgent need for European standards to ensure the quality of these devices.

Fixed-ratio combinations of basal insulin and GLP-1 receptor agonists (GLP-1 RA) have shown robust results as a treatment intensification option for people with type 2 diabetes.

The management of diabetic foot ulcers is a significant challenge, with amputation often being a necessary consequence. A novel approach using intact fish skin grafts, commonly used for burn wounds, has show...

Physical activity poses many challenges to people living with type 1 diabetes. A recently published position statement offers practical recommendations for the use of automated insulin delivery (AID) systems...

Kidney transplant recipients with type 1 diabetes who also receive an islet transplant profit from a significant reduction in the risk of death and the likelihood of returning to dialysis, a recent study sho...

In a recent randomised controlled trial, a whole-food, plant-based diet and exercise intervention was superior to standard medical care in improving glycaemic control, promoted diabetes remission and reduced...

A new consensus report offers key insights from over 6,000 articles on diabetic ketoacidosis and hyperglycaemic hyperosmolar state published since the previous 2009 consensus statement. Here we summarise how...

The FLOW trial brought GLP-1 receptor agonists (GLP-1 RAs) to the forefront of the discussion about chronic kidney disease and type 2 diabetes. A new subanalysis now sheds light on the concomitant use of GLP...

The recently published Clinical Practice Guidelines on metabolic dysfunction-associated steatotic liver disease (MASLD) was a joint effort of the European Association for the Study of the Liver (EASL), the E...

Artificial intelligence is going to revolutionise also the medical field, especially when it comes to harnessing existing data sets for practical applications. A Swedish consortium has now published its appr...

Metformin is typically taken with meals to reduce gastrointestinal side effects. However, recent data indicate that administering metformin before meals can improve glycaemic control and that this is linked ...

New research suggests that hypoglycaemia during sleep may have been underestimated by up to 30% in previous studies. The results were obtained by using continuous glucose monitoring (CGM) in addition to cust...

Determining which treatment is suited best for specific patient groups can be a complex challenge. A recent study proposes a simple roadmap to guide clinicians through the interpretation of subgroup meta-ana...